Esperion Therapeutics, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2025-05-29–present
Jay P. Shepard
Board Member
Esperion Therapeutics, Inc.
Equibles does not estimate personal net worth.
About Jay P. Shepard
Jay P. Shepard is recorded as Board Member at Esperion Therapeutics, Inc. since May 29, 2025. Esperion Therapeutics, Inc. reported in an 8-K filed June 2, 2025 that Jay P. Shepard was appointed Class III director, effective May 29, 2025. Esperion Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“The Company’s stockholders approved the Class III director nominees recommended for election in Proposal 1 at the Annual Meeting.”
Affiliation history
-
Esperion Therapeutics, Inc.
Board Member
SEC 8-K
Current2025-05-29–present